What is the management plan for Tetralogy of Fallot (TOF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tetralogy of Fallot

The management of Tetralogy of Fallot requires a staged approach with early complete surgical repair as the primary intervention, followed by lifelong surveillance for complications including arrhythmias, pulmonary valve dysfunction, and right ventricular abnormalities. 1, 2

Diagnosis and Initial Assessment

  • Diagnostic Evaluation:

    • Echocardiography: First-line assessment to evaluate RVOT obstruction, pulmonary regurgitation, RV function, and VSD 2
    • Cardiac MRI: Gold standard for RV volume quantification and pulmonary regurgitant fraction measurement 2, 3
    • Cardiac catheterization: For direct pressure measurements when non-invasive tests are inconclusive 2
    • ECG: To assess for arrhythmias and QRS duration (>180 ms indicates risk for ventricular arrhythmias) 2
  • Key Anatomical Features to Assess:

    • VSD type and size
    • Degree of RVOT obstruction
    • Pulmonary valve anatomy
    • Branch pulmonary artery anatomy
    • Coronary artery anatomy (to avoid interruption during surgery) 1, 2

Surgical Management

  • Timing of Repair:

    • Complete repair is typically performed between 3-6 months of age 4, 5
    • For symptomatic neonates <4 kg (hypercyanotic spells, ductal-dependent pulmonary circulation): Initial palliative modified Blalock-Taussig shunt followed by complete repair at 6-12 months 6
    • For asymptomatic patients <4 kg with threatened pulmonary artery isolation: Blalock-Taussig shunt followed by repair at 6-12 months 6
  • Surgical Approach:

    • Complete repair involves:
      • VSD closure
      • Relief of RVOT obstruction (infundibular muscle resection)
      • Pulmonary valvotomy or valve-sparing techniques when possible
      • Patch augmentation of RVOT/pulmonary arteries as needed 4

Long-term Follow-up and Management

  • Regular Surveillance:

    • Annual follow-up with cardiologist experienced in ACHD 1
    • Regular assessment of:
      • RV function and size
      • Pulmonary valve function
      • RVOT gradient
      • QRS duration
      • Exercise capacity 2
  • Imaging Schedule:

    • Echocardiography at each visit
    • CMR every 2-3 years or when clinical status changes 2
  • Arrhythmia Management:

    • Periodic Holter monitoring (individualized based on hemodynamics and clinical suspicion) 1
    • Electrophysiology testing for suspected arrhythmias 1
    • ICD implantation for documented sustained VT or cardiac arrest 1
    • Avoid class Ic antiarrhythmic medications and amiodarone in asymptomatic patients with VA 1, 2

Indications for Reintervention

  • Pulmonary Valve Replacement:

    • Severe pulmonary regurgitation with symptoms
    • RV dilation/dysfunction
    • Exercise intolerance 2
  • Branch Pulmonary Artery Intervention:

    • Stenosis causing unbalanced pulmonary blood flow 2
  • RVOT Obstruction:

    • Peak instantaneous echocardiography gradient >50 mm Hg
    • RV/LV pressure ratio >0.7 2

Special Considerations

  • Genetic Testing:

    • Screen for 22q11.2 microdeletion (present in many TOF patients)
    • Important for genetic counseling before pregnancy 1
  • Pregnancy Management:

    • Comprehensive cardiovascular evaluation before pregnancy
    • Generally well-tolerated if RV function is no more than mildly depressed and sinus rhythm is maintained 1
    • High-risk antepartum care may be warranted 1
    • Risk of CHD in offspring is approximately 4-6% in the absence of 22q11 deletion 1
  • Risk Factors for Sudden Cardiac Death:

    • QRS duration >180 ms
    • RV dilation and dysfunction
    • History of syncope
    • Older age at surgery
    • Residual hemodynamic lesions 1, 2

Common Pitfalls to Avoid

  • Underestimation of pulmonary regurgitation by echocardiography (use multiple imaging modalities)
  • Failure to recognize branch pulmonary artery stenosis
  • Overlooking coronary artery anomalies that may affect RVOT interventions
  • Misinterpreting RV dilation as primarily volume overload when residual RVOT obstruction may be contributing 2

The long-term survival rate for patients with repaired TOF is greater than 85%, though complications including pulmonary regurgitation, recurrent pulmonary stenosis, and ventricular arrhythmias require ongoing management throughout adulthood 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Haemodynamic Management in Tetralogy of Fallot

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular magnetic resonance in Tetralogy of Fallot-state of the art.

Cardiovascular diagnosis and therapy, 2025

Research

Tetralogy of Fallot.

Orphanet journal of rare diseases, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.